FindMyRecallSubscribe
Class III: unlikely to cause harmOngoing

Sun Pharmaceutical Industries Xelpros Recall

Xelpros (latanoprost ophthalmic emulsion) 0

SUN PHARMACEUTICAL INDUSTRIES INC · Princeton, NJ

Risk level
Class III
Reported by FDA
May 29, 2024
Recall ID
D-0502-2024
Check your lot numberHow we source this data

Summary

Sun Pharmaceutical Industries recalled Xelpros starting Apr 22, 2024. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0502-2024 on May 29, 2024. Reason: Failed Release Testing: Out of specification for particulate matter test. Status: Ongoing.

Why it was recalled

Failed Release Testing: Out of specification for particulate matter test.

Product description

Xelpros (latanoprost ophthalmic emulsion) 0.005%, 125mcg/2.5mL, 2.5 mL bottle, Rx only, Manufactured by: Sun Pharmaceutical Ind. Ltd., India., NDC 47335-317-90

Lot numbers, UPCs & expiration codes

Lot #: HAD3383A, Exp 8/31/2024

Where it was sold

TX, PA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0502-2024
Classification
Class III
Status
Ongoing
Recall initiated
Apr 22, 2024
FDA report date
May 29, 2024
Quantity
35,069 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
SUN PHARMACEUTICAL INDUSTRIES INC

Original FDA data

Every field from FDA enforcement report D-0502-2024, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Ongoing
Country
United States
Event ID
94465
Address
2 Independence Way
Code information
Lot #: HAD3383A, Exp 8/31/2024
Postal code
08540-6620
Report date
May 29, 2024
Product type
Drugs
Recall number
D-0502-2024
Classification
Class III
Recalling firm
SUN PHARMACEUTICAL INDUSTRIES INC
Product quantity
35,069 bottles
Reason for recall
Failed Release Testing: Out of specification for particulate matter test.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Xelpros (latanoprost ophthalmic emulsion) 0.005%, 125mcg/2.5mL, 2.5 mL bottle, Rx only, Manufactured by: Sun Pharmaceutical Ind. Ltd., India., NDC 47335-317-90
Distribution pattern
TX, PA
Recall initiation date
Apr 22, 2024
Initial firm notification
Letter
Center classification date
May 20, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0502-2024, published May 29, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls